Minerva Neurosciences Inc (NERV)

Currency in USD
2.380
+0.010(+0.42%)
Closed·
2.3800.000(0.00%)
·
NERV Scorecard
Full Analysis
Suffers from weak gross profit margins
NERV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.3522.460
52 wk Range
1.1503.000
Key Statistics
Prev. Close
2.38
Open
2.46
Day's Range
2.352-2.46
52 wk Range
1.15-3
Volume
3.43K
Average Volume (3m)
23.68K
1-Year Change
-14.39%
Book Value / Share
-4.59
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NERV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market

Minerva Neurosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Minerva Neurosciences Inc Company Profile

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of negative symptoms in patients with schizophrenia. The company also has exclusive rights to develop and commercialize MIN-301, a soluble recombinant form of the Neuregulin-1b1 protein for the treatment of Parkinson’s disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.

Compare NERV to Peers and Sector

Metrics to compare
NERV
Peers
Sector
Relationship
P/E Ratio
1.5x−2.9x−0.6x
PEG Ratio
0.010.000.00
Price/Book
−0.5x1.4x2.6x
Price / LTM Sales
-8.7x3.3x
Upside (Analyst Target)
111.0%202.6%39.1%
Fair Value Upside
Unlock5.6%5.4%Unlock

Earnings

Latest Release
Aug 14, 2025
EPS / Forecast
-0.43 / -0.90
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

NERV Income Statement

People Also Watch

3.0600
SNGX
+2.00%
18.34
SRPT
+1.49%
0.096
WINT
-6.76%
1.090
OTLK
-54.11%
14.8200
INKT
-7.26%

FAQ

What Stock Exchange Does Minerva Neurosciences Trade On?

Minerva Neurosciences is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Minerva Neurosciences?

The stock symbol for Minerva Neurosciences is "NERV."

What Is the Minerva Neurosciences Market Cap?

As of today, Minerva Neurosciences market cap is 16.64M.

What Is Minerva Neurosciences's Earnings Per Share (TTM)?

The Minerva Neurosciences EPS (TTM) is 1.48.

When Is the Next Minerva Neurosciences Earnings Date?

Minerva Neurosciences will release its next earnings report on 09 Nov 2025.

From a Technical Analysis Perspective, Is NERV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Minerva Neurosciences Stock Split?

Minerva Neurosciences has split 1 times.

How Many Employees Does Minerva Neurosciences Have?

Minerva Neurosciences has 8 employees.

What is the current trading status of Minerva Neurosciences (NERV)?

As of 29 Aug 2025, Minerva Neurosciences (NERV) is trading at a price of 2.380, with a previous close of 2.38. The stock has fluctuated within a day range of 2.352 to 2.460, while its 52-week range spans from 1.150 to 3.000.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.